Human Metabolome Technologies (HMT) is a Japan-headquartered biotechnology company founded in 2003 and global leader in capillary electrophoresis-mass spectrometry (CE-MS) based metabolome analysis. We established our United States headquarters in Boston, MA in 2012 and have spent the last 8 years developing solutions for a broad range of research endeavors in pharma, biotech, and food production.
Company Details
- Employees
- 14
- Founded
- 2003
- Address
- 24 Denby Rd, Suite 217,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- humanmetabolome.com
- Keywords
- Metabolomic profiling.
- HQ
- Boston, MA
Human Metabolome Technologies Questions
Human Metabolome Technologies's website is humanmetabolome.com
Human Metabolome Technologies's LinkedIn profile is https://www.linkedin.com/company/human-metabolome-technologies
Human Metabolome Technologies has
14 employees.
View email and phone details for 14
employees at Human Metabolome Technologies.
Human Metabolome Technologies's industry is
Biotechnology Research
Human Metabolome Technologies's top competitors are
Sunstone Compliance & Strategy Group,
Curry & Hickey Solicitors Llp,
Sysbiosim B.v.,
Mcm Vaccine B.v.,
Ometa Labs,
Metabbot | Metabolomics,
Eyesiu Medicines Bv,
Karrer Marketing,
Omicsiq,
West African Network For Tuberculosis, Aids And Malaria.
Human Metabolome Technologies's categories are Biotechnology Research
Human Metabolome Technologies's founding year is 2003
